J&J Paid $5.5B: Your Settlement Rights Cost Less

By Harvey Specter Jr. | Law, Business & Power | PUCKA by News Beast

---

$5.5 billion. 76,000 plaintiffs. Fifteen years of litigation that began with a single question nobody wanted to answer honestly: did Johnson & Johnson know, and did they sell it anyway? The settlement announced this week resolves 99.75% of the talcum powder cases moving through federal and state courts in the United States — which means the company's lawyers did the math, looked at what the remaining 0.25% might cost at trial, and decided this number was cheaper than the truth coming out in a courtroom.

That calculation is the only thing you need to understand about mass tort litigation. It is never about justice. It is about arithmetic. The moment the defendant's projected trial losses — multiplied by probability of losing, discounted for appeals, adjusted for reputational damage — exceed the settlement number, the cheque gets written. J&J wrote a very large cheque. Draw your own conclusions about what that means for the underlying facts.

What interests me more than the number is the architecture of how this case ran for fifteen years without resolution. J&J used every tool available — bankruptcy filings through subsidiaries, jurisdictional challenges, expert witness wars, appeals that reset the clock. A version of this playbook appears in Maltese commercial disputes regularly, just with smaller numbers and fewer lawyers. The principle is identical: if you can make the cost of winning higher than the value of winning, you don't need to win. You just need to outlast.

The people on the other side of J&J's lawyers were not corporations. They were individuals — mostly women, most of them ill — who had signed nothing, waived nothing, and whose only asset in the fight was the strength of their claim. In those early years, before the litigation consolidated into something with mass and momentum, most of them were invisible. Their lawyers worked on contingency, meaning they fronted the costs and got paid only if they won. That structure — the contingency fee — is one of the most important legal weapons a person without money can hold. Malta's legal system permits fee arrangements that approach this model, though the specifics matter enormously and vary by firm and by case type.

Here is what the J&J settlement teaches that no law school will frame this way: the first move in a mass harm situation is consolidation. Individual plaintiffs are easy to isolate, delay, and exhaust. Consolidated plaintiffs become a number that appears in board presentations and makes CFOs uncomfortable. In the United States, this happens through Multi-District Litigation. In Malta and across EU member states, the Collective Redress Directive — formally the Directive on Representative Actions for the Protection of the Collective Interests of Consumers, EU Directive 2020/1828, which Malta transposed — now creates a legal pathway for qualified entities to bring representative actions on behalf of consumers who have suffered the same harm from the same actor. The directive came into force for proceedings initiated from June 25, 2023 onward. Most people affected by corporate harm in Malta have never heard of it. Most companies operating here are banking on that.

I have a client right now — I won't say more than that — whose situation rhymes with the early J&J pattern. A product. A harm. A company whose legal team is considerably better resourced than hers. The difference between her position eighteen months ago and her position now is not money. It is the reframing of her claim from individual grievance to documented pattern. Once you show a pattern, you stop being a complaint and start being a liability that has to be managed. Companies settle patterns. They fight individual claims.

The negotiation tactic at the heart of every mass tort resolution is what I call the ledger flip. You go into the room not with what you're owed but with what continuing to fight will cost them — in legal fees, in discovery, in the documents they do not want produced in a courtroom, in the executive time that gets consumed by depositions. You put their number on the table before they put yours. You let them look at it. Then you wait. The first person who speaks after that silence usually loses. J&J eventually ran out of silence.

Fifteen years is a long time. Too long. The lesson for anyone sitting on a legitimate claim against a well-resourced defendant is not to wait for a mass tort consolidation that may never come — it's to make the cost of delay visible as early as possible. A well-drafted letter before action,